These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit. Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913 [TBL] [Abstract][Full Text] [Related]
25. Endoscopic removal of esthesioneuroblastoma. Cakmak O; Ergin NT; Yilmazer C; Kayaselçuk F; Barutcu O Int J Pediatr Otorhinolaryngol; 2002 Jul; 64(3):233-8. PubMed ID: 12090952 [TBL] [Abstract][Full Text] [Related]
26. Esthesioneuroblastoma in a young child. Gül B; Kulaçoğlu S; Yüksel M; Doğan H; Okten AI Neurosurg Rev; 1997; 20(1):59-61. PubMed ID: 9085290 [TBL] [Abstract][Full Text] [Related]
27. [Esthesioneuroblastoma: lidswelling as a primary symptom of a nasal tumor]. von Bülow MN; Caselitz J; Rieckhoff K; Grundmann T; Schaudig U Klin Monbl Augenheilkd; 2008 Oct; 225(10):890-1. PubMed ID: 18951311 [No Abstract] [Full Text] [Related]
28. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088 [TBL] [Abstract][Full Text] [Related]
29. Olfactory neuroblastoma. A report of 5 cases. Butugan O; Bogar P; Sennes LU; Ognibene R; Ishida L; da Silveira JA; Rosemberg S; Miniti A Rev Laryngol Otol Rhinol (Bord); 1993; 114(5):359-63. PubMed ID: 8059104 [TBL] [Abstract][Full Text] [Related]
30. Remote orbital recurrence of olfactory neuroblastoma (esthesioneuroblastoma). Breazzano MP; Lewis JS; Chambless LB; Rohde SL; Sobel RK Orbit; 2017 Aug; 36(4):247-250. PubMed ID: 28362545 [TBL] [Abstract][Full Text] [Related]
36. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404 [TBL] [Abstract][Full Text] [Related]
37. Oral & maxillofacial manifestations in pediatric esthesioneuroblastoma-report of a case and review of literature. Padmanabhan MY; Pandey RK; Kumar A; Tandon V Pediatr Dent; 2011; 33(3):261-4. PubMed ID: 21703080 [TBL] [Abstract][Full Text] [Related]
38. Volumetric analysis of olfactory neuroblastoma skull base laterality and implications on neck disease. Marinelli JP; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Lees KA; Kaczor MW; Janus JR Laryngoscope; 2018 Apr; 128(4):864-870. PubMed ID: 28833165 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. Lodde M; Lacombe L; Friede J; Morin F; Saourine A; Fradet Y BJU Int; 2010 Sep; 106(5):658-63. PubMed ID: 20151968 [TBL] [Abstract][Full Text] [Related]
40. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]